Artwork

Innhold levert av Rodney Moses. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Rodney Moses eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

STOP BLEEDING wounds in SECONDS; 100 MILLION US Dollars Raised! with Joe Landolina, CEO Co-Founder of Cresilon| Episode 14 (Part 2)

32:28
 
Del
 

Manage episode 371569082 series 3465164
Innhold levert av Rodney Moses. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Rodney Moses eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Send us a Message

At 17, Joe invented a Gel that prevents excessive wound blood loss (Patent #: BR112014011442A8). This led to the creation of Cresilon. The company recently got FDA Approved. Raising 100 MILLION USD Dollars along the way!! He was also listed on the Forbes 30 under 30 for 2023 North America ( https://www.forbes.com/30-under-30/2023/healthcare?profile=joe-landolina )
This is an Exciting Discussion covering many points!!
Timestamp:
00:00 Part 2 Intro
00:59 Walter Reed Army Institute of Research
04:34 Importance of partnerships for companies
06:19 Intended use duration of CHG
08:39 Equilibrium point of CHG
11:09 Possible Integration of Antibiotics
12:46 Hiring
13:46 What motivates Joe Landolina
16:15 Diverse Team at Cresilon
19:18 Cresilon location
21:58 Joe’s Thoughts on the Future
24:04 Trauma Care for Average People
25:46 The process of Inventing a medical device
29:39 Juggling R&D and Finance in a start-up as CEO
Cresilon Links:
https://cresilon.com/
https://www.forbes.com/profile/joe-landolina/?list=30under30-healthcare%2F

Support the show

Follow or Connect with Rodney Moses:
Instagram | LinkedIn | YouTube |
Donations
Patreon | PayPal

  continue reading

46 episoder

Artwork
iconDel
 
Manage episode 371569082 series 3465164
Innhold levert av Rodney Moses. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Rodney Moses eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

Send us a Message

At 17, Joe invented a Gel that prevents excessive wound blood loss (Patent #: BR112014011442A8). This led to the creation of Cresilon. The company recently got FDA Approved. Raising 100 MILLION USD Dollars along the way!! He was also listed on the Forbes 30 under 30 for 2023 North America ( https://www.forbes.com/30-under-30/2023/healthcare?profile=joe-landolina )
This is an Exciting Discussion covering many points!!
Timestamp:
00:00 Part 2 Intro
00:59 Walter Reed Army Institute of Research
04:34 Importance of partnerships for companies
06:19 Intended use duration of CHG
08:39 Equilibrium point of CHG
11:09 Possible Integration of Antibiotics
12:46 Hiring
13:46 What motivates Joe Landolina
16:15 Diverse Team at Cresilon
19:18 Cresilon location
21:58 Joe’s Thoughts on the Future
24:04 Trauma Care for Average People
25:46 The process of Inventing a medical device
29:39 Juggling R&D and Finance in a start-up as CEO
Cresilon Links:
https://cresilon.com/
https://www.forbes.com/profile/joe-landolina/?list=30under30-healthcare%2F

Support the show

Follow or Connect with Rodney Moses:
Instagram | LinkedIn | YouTube |
Donations
Patreon | PayPal

  continue reading

46 episoder

كل الحلقات

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett